Baudax Bio to Report Second Quarter 2020 Financial Results

Baudax Bio, Inc.

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) announced that it will report second quarter 2020 financial results on Monday, August 10, 2020.

Baudax’s management team will host a conference call and audio webcast at 9:00 a.m. ET on Monday, August 10, 2020 to discuss the financial results and recent operational highlights.

To access the conference call please dial (866) 220-5595 (local) or (615) 622-8062 (international) at least 10 minutes prior to the start time and refer to conference ID 6734469.

A live audio webcast of the call will be available under “Events” in the Investor section of the Company’s website, https://www.baudaxbio.com/news-and-investors/events.

An archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.

Baudax Bio is a specialty pharmaceutical company focused on therapeutics for acute care settings.

READ:  Zynerba Pharmaceuticals Announces Oral Presentations at the Virtual American Academy of Child and Adolescent Psychiatry 2020 Annual Meeting

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee